ImmunAdd Inc.
PrivateLast Round
Series A
Nov 1, 2025
Total Funding Raised
$16M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ImmunAdd Inc. is a biopharmaceutical company that develops next-generation synthetic saponin-based vaccine adjuvants and immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunAdd Inc. Comparables
Compare ImmunAdd Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adjuvance Technologies | 88% | |
| HotHouse Therapeutics | 81% | |
| LiteVax B.V. | 79% |
ImmunAdd Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 1, 2025 | ||||
| Pre Seed | Aug 1, 2023 | ||||
| Grant | Jul 1, 2022 |
Key People
Founding team and executive leadership
ImmunAdd Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Diamond BioFund | Pre Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
$15M round led by Diamond BioFund.
- Aug 1, 2023
Diamond BioFund participated in the round.
ImmunAdd Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmunAdd Inc.'s valuation, stock price, and market status.
Is ImmunAdd Inc. a public or private company?
ImmunAdd Inc. is a private company.
What is the current stock price of ImmunAdd Inc.?
ImmunAdd Inc. is a private company, so its shares have no public market price. Caplight tracks ImmunAdd Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmunAdd Inc. worth (valuation)?
Valuation information for ImmunAdd Inc. is not publicly available.
Can I buy ImmunAdd Inc. stock?
ImmunAdd Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmunAdd Inc.'s last funding round?
ImmunAdd Inc.'s most recent funding round was Series A on November 1, 2025.
Who are the main investors in ImmunAdd Inc.?
Key investors in ImmunAdd Inc. include Diamond BioFund.
Will ImmunAdd Inc. IPO soon?
No public IPO plans have been announced for ImmunAdd Inc..
How can I track ImmunAdd Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ImmunAdd Inc.'s shares on secondary markets.